Hematology

A new study shows that more than 50% of patients with newly diagnosed lymphoma or myeloma suffer from anxiety and depression, significantly impacting their quality of life.

EBMT Interview: Luigi Naldini and Franco Locatelli. In this insightful interview, leading experts in gene therapy, Franco Locatelli and…

A new study shows that prothrombin complex concentrate (PCC) offers superior bleeding control and fewer complications than frozen plasma in cardiac surgery patients.

In this insightful interview, Nicoletta Sacchi discusses her Nurses Keynote Lecture, presented at EBMT 2025, and the importance of donor…

Thank you. We are both truly honoured to step into these leadership roles and continue the great work initiated by Nico, Claire and other…

Most patients with multiple myeloma undergo several cycles of remission and relapse during their disease journey, and multiple lines of…

A study at EBMT 2025 shows improved outcomes for relapsed lymphoma patients using CAR-T cell therapy with stem cell transplantation.

HSCT shows promising results as a cure for very early-onset inflammatory bowel disease caused by IL-10 receptor deficiency.